SCHEMBL29930798

SCHEMBL29930798

Cc1ccc(-c2ccccn2)c(C(=N)N)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.41
TP53 P04637 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
IKBKB O14920 1/20 0.41
HSD17B10 Q99714 1/20 0.40
PDE10A Q9Y233 1/20 0.40
F2 P00734 1/20 0.39
F10 P00742 1/20 0.39
F7 P08709 1/20 0.39
GRM5 P41594 3/20 0.39
KDM4E B2RXH2 5/20 0.38
TGFBR1 P36897 2/20 0.38
LMNA P02545 2/20 0.38
CCR1 P32246 2/20 0.38
CCR5 P51681 2/20 0.38
CCR8 P51685 2/20 0.38
CYP1A2 P05177 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30761191 0.88 IKBKB (0.49) NPC1TP53SMN1; SMN2HPGDRAB9A
SCHEMBL30775055 0.80 KDM4E (0.48) NPC1TP53SMN1; SMN2HPGDRAB9A
SCHEMBL3385678 0.80 KDM4E (0.48) NPC1TP53SMN1; SMN2HPGDRAB9A
SCHEMBL20780897 0.79 NPC1 (0.45) NPC1TP53SMN1; SMN2HPGDRAB9A
SCHEMBL7910798 0.79 KDM4E (0.46) NPC1TP53SMN1; SMN2HPGDRAB9A
SCHEMBL20773709 0.77 L3MBTL1 (0.46) NPC1TP53SMN1; SMN2HPGDRAB9A
SCHEMBL30775039 0.77 L3MBTL1 (0.46) NPC1TP53SMN1; SMN2HPGDRAB9A
SCHEMBL10262377 0.75 KDM4E (0.48) NPC1TP53SMN1; SMN2HPGDRAB9A
Hydrochloric Acid SCHEMBL31267313 0.69 KDM4E (0.45) NPC1TP53SMN1; SMN2HPGDRAB9A
SCHEMBL19700489 0.69 PRSS1 (0.42) RAB9AIKBKBGRM5KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114989173-A Imidazole compound, pharmaceutical composition and application thereof 广州市恒诺康医药科技有限公司 2022-09-02 CN disclosed